Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The emergence of thrombocardiolgy

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Plato. Timaeus. In: Jewett B, ed.The Dialogues of Plato, 3rd ed., Vol. 3. New York: Macmillan, 1892:508.

  2. 2.

    Aristotle. Meteorologica (Lee HDP, translator). Loeb Classical Library. Cambridge, MA: Harvard University Press, 1952.

  3. 3.

    Galen C.On the Natural Faculties (Brock AJ, translator). Cambridge, MA: Harvard University Press, 1916.

  4. 4.

    Petit JL. Dissertation sur la manniere d'arrester le sang dans le hemorrhagies.Mem Acad R Sci 1731;l:85–102.

  5. 5.

    Bizzozero G. Ueber eine neuen formbestandtheil des blutes und desen rolle bei der thrombose und der blutgerinnung.Virchows Arch Pathol Anat 1882;90:261–332.

  6. 6.

    Eberth JC, Schimmelbusch C. Experimentalle untersuchungen uber thrombose.Virchows Arch Pathol Anat 1886;103:39–87.

  7. 7.

    Malpighi M.De Polypo Cordis, 1686 (Forester JM, translator). Uppsala: Almquist & Wiksels, 1956.

  8. 8.

    Schmidt A.Zur Blutlehre. Leipzig: Vogel, 1892.

  9. 9.

    Lister J. On the coagulation of the blood.Proc R Soc Lond 1863;12:580–611.

  10. 10.

    Thackrah CT.An Inquiry into the Nature and Properties of the Blood. London: Cox & Sons, 1819.

  11. 11.

    Morawitz P. The chemistry of blood coagulation.Ergebn Physiol 1905;4:307–422.

  12. 12.

    Otto JC. An account of an hemorrhagic disposition existing in certain families.Med Repository 1803;6:l-4.

  13. 13.

    Hay J. Account of a remarkable haemorrhagic disposition, existing in many individuals of the same family.N Engl Med Surg 1813;2:221–225.

  14. 14.

    Von Willebrand EA. Uber hereditare pseudohamophilie.Acta Med Scand 1931;76:531–549.

  15. 15.

    Dam H. Cholestrinstoffwechsel in huhnereiern und huhnchen.Biochem Z 1929;215:475–492.

  16. 16.

    Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci.J Exp Med 1933;58:485–502.

  17. 17.

    Donnè A. De l'origine des globules du sang, de leur mode de formation et leur fin (abstract).C R Acad Sci (Paris) 1842;14:366–368.

  18. 18.

    Osler W. An account of certain organisms occurring in the liquor sanguinis.Proc R Soc Lond 1874;22:391–398.

  19. 19.

    Master AM, Dack S, Jaffe HL. Activities associated with the onset of acute coronary artery occlusion.Am Heart J 1939;18:434–443.

  20. 20.

    Dzau V, Braunwald E, and participants. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement.Am Heart J 1991;121:1244–1263.

  21. 21.

    Mann CC, Plummer ML.The Aspirin Wars: Money, Medicine and 100 Years of Rampant Competition. New York: Alfred A. Knopf, 1991:1–420.

  22. 22.

    Schindler PE.Aspirin Therapy. New York: Walker and Company, 1978:1–134.

  23. 23.

    Craven LL. Acetylsalicylic acid, possible preventive of coronary thrombosis.Ann West Med Surg 1950;4:95.

  24. 24.

    Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.Miss Valley Med J 1953;75:38–40.

  25. 25.

    Craven LL. Prevention of coronary and cerebral thrombosis.Miss Valley Med J 1956;78:213–215.

  26. 26.

    Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man.J Clin Invest 1968;47:2169–2180.

  27. 27.

    Wilander O. Studien uber heparin.Scand Arch Physiol 1939;S15:81:l-89.

  28. 28.

    Pavlov IP.Biokhimya Sventyvaniya Krovi. Kiev: YV Belik; 1957. Reprinted OTS Washington, US Joint Publications Research Service, February 1959.

  29. 29.

    Crafoord C. Preliminary report on postoperative treatment with heparin as a preventive of thrombosis.Acta Chir Scand 1937;79:407–426.

  30. 30.

    Wright IS, Marple CD, Beck DF. Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction.Am Heart J 1948;36:801–815.

  31. 31.

    Von Brucke E. Die verdauende Substanz im urin.SB Akad Wiss (Vienna) 1861;43:601–615.

  32. 32.

    Sobel GW, Mohler SR, Jones NW, Dowdy ABC, Guest MM. Urokinase: An activator of plasma proflbrinolysis extracted from urine.Am J Physiol 1952;171:768–769.

  33. 33.

    Sherry S. Personal reflections on the development of thrombolytie therapy and its application to acute coronary thrombosis.Am Heart J 1981;102:1134–1139.

  34. 34.

    Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis.J Immunol 1941;42:109–116.

  35. 35.

    Sherry S. The origin of thrombolytic therapy.J Am Coll Cardiol 1989;14:1085–1092.

  36. 36.

    Johnson AJ, Tillett WS. Lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).J Exp Med 1952;95:449–464.

  37. 37.

    Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. Treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy.Trans Assoc Am Physicians 1958;71:287–296.

  38. 38.

    Chazov EL, Mateeva LS, Mazaev AV, Sargin KE, Sadovshaya M, Ruda Y. Intracoronary administration of fibrinolysin in acute myocardial infarction.Ter Arkh 1976;48:8–19.

  39. 39.

    Rentrop KP, Blanke H, Kostering K, Karsch KR. Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization.Clin Cardiol 1979;2:354–363.

  40. 40.

    Rijken DC, Wijngaards G, Zaal-De Jong M, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue.Biochim Biophys Acta 1979;580:140–153.

  41. 41.

    Pennica D, Holmes WE, Kohr WJ, et al. Cloning and expression of human tissue-type plasminogen activator cDNA inE coli.Nature 1983;301:214–221.

  42. 42.

    Collen D, Topol EJ, Tiefenbrunn AJ, et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: A prospective, randomized, placebo-controlled trial.Circulation 1984;69:1012–1017.

Download references

Author information

Correspondence to Richard C. Becker.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Becker, R.C. The emergence of thrombocardiolgy. J Thromb Thrombol 1, 41–43 (1994). https://doi.org/10.1007/BF01061994

Download citation